Mitchell S.V. Elkind

Columbia University Medical Center, Department of Neurology

College of Physicians and Surgeons

630 West 168th Street, 3rd Floor, Suite 3-470

New York, NY 10032-3784

United States

SCHOLARLY PAPERS

4

DOWNLOADS

281

TOTAL CITATIONS

2

Scholarly Papers (4)

1.

Clinical Review of Cerebral Venous Thrombosis in the Context of COVID-19 Vaccinations: Evaluation, Management, and Scientific Questions

Number of pages: 20 Posted: 26 May 2021
Department of Neurology - Columbia University Irving Medical Center, University of Liverpool - Institute of Infection and Global Health, University of Liverpool - Institute of Infection and Global Health, Columbia University - New York Presbyterian, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - New York Presbyterian, Columbia University - New York Presbyterian, Columbia University - New York Presbyterian, Columbia University - Division of Hospital and Critical Care Neurology, Cornell University - Department of Neurology, Moscow Research and Clinical Center for Neuropsychiatry, Johns Hopkins University - School of Medicine, Columbia University - New York Presbyterian, University of Valladolid - Department of Neurology, Rajendra Institute of Medical Sciences, Medical University of Innsbruck, Harvard University - Massachusetts General Hospital, University of Pittsburgh - Departments of Critical Care Medicine, Neurology, and Neurosurgery, Technical University of Munich - Center for Global Health, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences and Columbia University Medical Center, Department of Neurology
Downloads 103 (529,553)
Citation 1

Abstract:

Loading...

Cerebral Venous Thrombosis, Adenovirus Vaccine, COVID-19, Anticoagulation, Thrombocytopenia

Risk Factors for New Neurological Diagnoses in Hospitalized COVID-19 Patients: A Case-Control Study in New York City

Number of pages: 32 Posted: 04 Jan 2022 Last Revised: 10 Jan 2022
Department of Neurology - Columbia University Irving Medical Center, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Cornell University - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), University of Colorado, Aurora - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Irving Medical Center, Columbia University, College of Physicians & Surgeons, Department of Pediatrics, Columbia University - Department of Neurology, University of North Carolina (UNC) at Chapel Hill - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Columbia University - Division of Hospital and Critical Care Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Department of Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Division of Infectious Diseases, Government of the United States of America - Division of High Consequence Pathogens and Pathology and Government of the United States of America - Division of High Consequence Pathogens and Pathology
Downloads 70 (677,367)

Abstract:

Loading...

COVID-19, SARS-CoV-2, neurological diagnoses, encephalopathy

Risk Factors for New Neurological Diagnoses in Hospitalized COVID-19 Patients: A Case-Control Study in New York City

Number of pages: 28 Posted: 06 Jan 2022
Department of Neurology - Columbia University Irving Medical Center, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Cornell University - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), University of Colorado, Aurora - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Columbia University - Division of Hospital and Critical Care Neurology, Cornell University - Department of Neurology, Cornell University - Department of Neurology, Columbia University - Irving Medical Center, Columbia University, College of Physicians & Surgeons, Department of Pediatrics, Columbia University - Department of Neurology, University of North Carolina (UNC) at Chapel Hill - Department of Neurology, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Columbia University - Division of Hospital and Critical Care Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Department of Neurology, Columbia University Medical Center, Department of Neurology, Columbia University - Aaron Diamond AIDS Research Center, Columbia University - Division of Infectious Diseases, Government of the United States of America - Division of High Consequence Pathogens and Pathology and Government of the United States of America - Division of High Consequence Pathogens and Pathology
Downloads 18 (1,110,046)

Abstract:

Loading...

COVID-19, SARS-CoV-2, neurological diagnoses, Encephalopathy

3.

Determinants of Poor Outcome after Intracerebral Hemorrhage: Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study

Number of pages: 32 Posted: 03 Sep 2019
University of Cincinnati - Department of Neurology and Rehabilitation Medicine, Wake Forest University - Department of Biostatistics and Data Science, Utrecht University - Department of Neurology and Neurosurgery, Harvard University - Center for Genomic Medicine, University of Cincinnati - Department of Neurology and Rehabilitation Medicine, University of Illinois at Chicago - Department of Neurology and Rehabilitation Medicine, University of Maryland - Baltimore Veterans Administration Medical Center, Emory University - Department of Neurology, Duke University - Departments of Anesthesiology and Neurology, University of Southern California - Neurocritical Care and Stroke Division, Columbia University Medical Center, Department of Neurology, University of Virginia - Department of Neurology, University of Arizona - Department of Neurology, University of Texas at Houston - Department of Neurology, University of Miami - Department of Neurology, University of Texas at Dallas - Department of Neurology and Neurotherapeutics, University of Texas at San Antonio - Department of Neurology, Georgetown University - Department of Neurology, University of Arizona - Department of Neurology, University of Tennessee, Memphis - Department of Neurology and Neurosurgery, Yale University - Department of Neurology, University of Miami - John P Hussman Institute for Human Genomics, University of Cincinnati - Department of Neurology and Rehabilitation Medicine, University of Cincinnati - Department of Neurology and Rehabilitation Medicine, University of Cincinnati - Department of Neurology and Rehabilitation Medicine, University of Cincinnati - Department of Neurology and Rehabilitation Medicine, University of Cincinnati - Department of Neurology and Rehabilitation Medicine, University of Cincinnati - Department of Neurology and Rehabilitation Medicine, University of Cincinnati - Department of Neurology and Rehabilitation Medicine, Harvard University - Center for Genomic Medicine and Wake Forest University - Department of Biostatistics and Data Science
Downloads 49 (787,675)
Citation 1

Abstract:

Loading...

4.

Cost-Effectiveness of an Insertable Cardiac Monitor in a High-Risk Population in the US

Number of pages: 42 Posted: 06 Feb 2021
Columbia University Medical Center, Department of Neurology, University of Leeds, Symmetron Limited, Symmetron Limited, Symmetron Limited, Medtronic, Medtronic, Medtronic and Baim Institute for Clinical Research, Boston, MA and Lahey Hospital & Medical Center
Downloads 41 (846,502)

Abstract:

Loading...